Vanguard Group Inc Gossamer Bio, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,754,397 shares of GOSS stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,754,397
Previous 11,760,251
0.05%
Holding current value
$10.1 Million
Previous $10.6 Million
9.94%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$15.6 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$11.4 Million0.65% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$7.9 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$6.93 Million4.79% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.43MShares$5.53 Million0.0% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $80.8M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...